New Results
Ameliorative effect of a quinazoline-based bromodomain inhibitor, CN210, on experimentally-induced Crohn’s disease-like murine ileitis via inhibition of inflammatory cytokine expression
Takehisa Noguchi, Kyosuke Hidaka, Satsuki Kobayashi, Kenjiro Matsumoto, Makoto Yoshioka, Shyh-Ming Yang, David J. Maloney, View ORCID ProfileShinichi Kato
doi: https://doi.org/10.1101/2020.01.24.917948
Takehisa Noguchi
1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan
Kyosuke Hidaka
1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan
Satsuki Kobayashi
1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan
Kenjiro Matsumoto
1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan
Makoto Yoshioka
2ConverGene LLC, 3093 Beverly Lane, Unit C, Cambridge, MD 21613, USA
Shyh-Ming Yang
3National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA
David J. Maloney
3National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA
Shinichi Kato
1Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Kyoto, Japan

Article usage
Posted January 24, 2020.
Ameliorative effect of a quinazoline-based bromodomain inhibitor, CN210, on experimentally-induced Crohn’s disease-like murine ileitis via inhibition of inflammatory cytokine expression
Takehisa Noguchi, Kyosuke Hidaka, Satsuki Kobayashi, Kenjiro Matsumoto, Makoto Yoshioka, Shyh-Ming Yang, David J. Maloney, Shinichi Kato
bioRxiv 2020.01.24.917948; doi: https://doi.org/10.1101/2020.01.24.917948
Ameliorative effect of a quinazoline-based bromodomain inhibitor, CN210, on experimentally-induced Crohn’s disease-like murine ileitis via inhibition of inflammatory cytokine expression
Takehisa Noguchi, Kyosuke Hidaka, Satsuki Kobayashi, Kenjiro Matsumoto, Makoto Yoshioka, Shyh-Ming Yang, David J. Maloney, Shinichi Kato
bioRxiv 2020.01.24.917948; doi: https://doi.org/10.1101/2020.01.24.917948
Subject Area
Subject Areas
- Biochemistry (4957)
- Bioengineering (3456)
- Bioinformatics (15148)
- Biophysics (6868)
- Cancer Biology (5365)
- Cell Biology (7692)
- Clinical Trials (138)
- Developmental Biology (4509)
- Ecology (7117)
- Epidemiology (2059)
- Evolutionary Biology (10193)
- Genetics (7494)
- Genomics (9758)
- Immunology (4808)
- Microbiology (13153)
- Molecular Biology (5114)
- Neuroscience (29321)
- Paleontology (203)
- Pathology (833)
- Pharmacology and Toxicology (1458)
- Physiology (2123)
- Plant Biology (4723)
- Synthetic Biology (1336)
- Systems Biology (3997)
- Zoology (768)